SRI and Stanford Cancer Institute in ‘first-in-class’ collaboration
10 December 2015 | By Victoria White
SRI Biosciences and physician-researchers from Stanford Cancer Institute (SCI) are to pursue development of novel compounds to treat multiple forms of cancer and other conditions...